We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

DMS Imaging SA (ALIMG) NPV

Sell:€0.019 Buy:€0.0222 Change: €0.0002 (0.89%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Sell:€0.019
Buy:€0.0222
Change: €0.0002 (0.89%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Sell:€0.019
Buy:€0.0222
Change: €0.0002 (0.89%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DMS Imaging SA, formerly known as Asit Biotech SA is a France-based high-tech company. The Company is based in the south of France specialized in medical imaging diagnostics. It’s brands include Apelem, DMS, AXS Medical and Medilink, which offer a range of solutions in radiology, bone densitometry, stereo-radiography and post urology, all of which are adapted to the demands of the global marketplace. The Company serves across 140 countries through it’s subsidiaries and joint-ventures. It generates maximum of the turnover through the exportation market.

Contact details

Address:
Avenue Louise 231
BRUXELLES
1050
Belgium
Telephone:
+32 (4) 67504900
Website:
https://www.dms-imaging.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALIMG
ISIN:
BE0974289218
Market cap:
€33.67 million
Shares in issue:
1.49 billion
Sector:
Biotechnology
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Regis Roche
    Chairman of the Board
  • Frank Hazevoets
    Chief Executive Officer, Chief Financial Officer, Director
  • Gael Placier
    Senior Product Development Manager
  • Francois Meurgey
    Marketing & Commercialization, Director
  • Marie-Claire Beckers
    Head of Production
  • Adrian Caplanusi
    Senior Medical Director
  • Sacha Gogev
    Head of Quality Control
  • Sabine Pirotton
    Senior Clinical Project Manager
  • Albert Vicaire
    Secretary of the company

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.